ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BCRX BioCryst Pharmaceuticals Inc

4.21
0.00 (0.00%)
Pre Market
Last Updated: 07:39:57
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
BioCryst Pharmaceuticals Inc BCRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 4.21 07:39:57
Open Price Low Price High Price Close Price Prev Close
4.21
more quote information »

Recent News

Date Time Source Heading
4/22/202407:00GLOBEBioCryst to Report First Quarter 2024 Financial Results on..
4/17/202404:30GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
4/03/202407:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
3/25/202416:01GLOBEBioCryst to Present at Upcoming Investor Conferences
3/05/202407:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
3/04/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202417:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2/26/202407:05EDGAR2Form 8-K - Current report
2/26/202407:00GLOBEBioCryst Reports Fourth Quarter and Full Year 2023 Financial..
2/26/202405:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
2/23/202407:00GLOBEBioCryst Presents New Real-world Data Showing Rapid,..
2/21/202416:01GLOBEBioCryst to Present at Upcoming Investor Conferences
2/19/202407:54GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Italy
2/14/202416:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202409:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202407:00GLOBEBioCryst to Report Fourth Quarter 2023 Financial Results on..
2/05/202407:00GLOBEBioCryst to Present New ORLADEYO® (berotralstat) Real-world..
2/02/202407:00GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
1/24/202417:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/18/202417:21EDGAR2Form 8-K - Current report
1/08/202407:02EDGAR2Form 8-K - Current report
1/05/202416:01GLOBEBioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
1/04/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202416:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
1/03/202407:00GLOBEBioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
12/20/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202316:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/19/202307:00GLOBEBioCryst Announces Publication of Data from Open-label..
12/18/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/05/202316:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
12/01/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202307:37EDGAR2Form 8-K - Current report
11/30/202309:04EDGAR2Form 8-K - Current report
11/29/202307:00GLOBEBioCryst Announces Approval of ORLADEYO® (berotralstat) by..
11/21/202316:01GLOBEBioCryst to Present at Upcoming Investor Conferences
11/21/202307:00GLOBEBioCryst Launches ORLADEYO® (berotralstat) in Spain
11/10/202307:00GLOBEBioCryst Presents New Real-world Data Showing Reduced Attack..
11/08/202316:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/08/202316:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/06/202316:01GLOBEBioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
11/03/202312:16EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock